Ahmed Elsharkawy/LinkedIn
Sep 23, 2026, 00:02
Ahmed Elsharkawy: Drug-Drug and Drug-Diluent Incompatibilities in ICUs and Hematology Units
Ahmed Elsharkawy, ICU and Oncology Clinical Pharmacist at Children’s Cancer Hospital Foundation 57357, shared a post on LinkedIn:
“One of the major roles of Clinical pharmacist is to check Drug-Drug and Drug-Diluent incompatibilities especially for patients in ICUs and hematology units as they are considered a high-risk group for the occurrence of incompatibilities because they commonly require the use of multiple drugs, most of which are administered intravenously and by continuous infusion.
Potential complications of co-administration of incompatible drugs include:
- Precipitation
- Central venous catheter (CVC) occlusion or malfunction
- Reduced potency of medication
- Embolism and local or systemic inflammatory reactions.”
Stay updated with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience